Pfizer Inc
Close on Oct 30, 2026Market cap $173.95BP/E 40.2Yield 5.64%
Pfizer Biopharma Segment — Depreciation & amortization by Quarter
Biopharma Segment — Depreciation & amortization ($M) ($M)
Pfizer Biopharma Segment — Depreciation & amortization: $324M in Q2 2026, down 4.4% from a year earlier. That is the lowest of the 10 quarters on record here.
Where the Q2 2026 figure comes from
Source: Form 10-Q (filed 2026-08-04) ↗
Reported in Form 10-Q / 10-K Note 17 — Segment Reporting (ASU 2023-07 Significant Segment Expenses).
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Biopharma Segment — Depreciation & amortization ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 28, 2026 | 324 | -4.4% | Form 10-Q (filed 2026-08-04) ↗ |
| Q1 2026 | Mar 29, 2026 | 348 | +5.1% | Form 10-Q (filed 2026-05-05) ↗ |
| Q4 2025 | Dec 31, 2025 | 350 | +2.3% | Form 10-K (filed 2026-02-26) ↗ |
| Q3 2025 | Sep 28, 2025 | 358 | +2.0% | Form 10-Q (filed 2025-11-04) ↗ |
| Q2 2025 | Jun 29, 2025 | 339 | +2.7% | Form 10-Q (filed 2026-08-04) ↗ |
| Q1 2025 | Mar 30, 2025 | 331 | -1.8% | Form 10-Q (filed 2026-05-05) ↗ |
| Q4 2024 | Dec 31, 2024 | 342 | – | Form 10-K (filed 2026-02-26) ↗ |
| Q3 2024 | Sep 29, 2024 | 351 | – | Form 10-Q (filed 2025-11-04) ↗ |
| Q2 2024 | Jun 30, 2024 | 330 | – | Form 10-Q (filed 2025-08-05) ↗ |
| Q1 2024 | Mar 31, 2024 | 337 | – | Form 10-Q (filed 2025-05-05) ↗ |
Cite this data
StockData. (2026). Pfizer Biopharma Segment — Depreciation & amortization ($M), quarterly Q1 2024–Q2 2026 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/seg-da-bio
See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.